InvestorsHub Logo
Followers 21
Posts 2302
Boards Moderated 0
Alias Born 06/19/2017

Re: tbonaces80 post# 25295

Wednesday, 05/06/2020 10:23:21 AM

Wednesday, May 06, 2020 10:23:21 AM

Post# of 40503
I agree w/ 200-300% move in near future.

As a comparison:
Moderna, MRNA
~15B = Market Cap (MC)
~60M = Yearly Revenue
~53% = Institutional Ownership
mRNA = Vaccine Platform
https://www.modernatx.com/pipeline

Inovio, INO
~1.6B = MC
~4.1M = Rev
~30% = IO
DNA = VP
https://www.inovio.com/dna-medicines-pipeline/

Basically, both companies have:
• No revenues
• Very promising pipelines
• Novel technology platforms and not proven yet (as so many R working towards)
• Leading vaccine candidates <<<<<<<<<


One huge difference is Moderna is more fully priced.

Within the coming months as we move closer, INO should have IO increase substantially and take the SP to $20-$40 and hold it there. And it will move sooo fast.

To me, this is a buy and hold and revisit in 4 months stock.

Daily fluctuations mean nothing at this point (unless wish to buy).

And if INO-4800 is safe, effective & works, $100+ SP with a tender $200+ (~$30B MC).

GLTAL, Scruffer

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News